CIITA Antikörper (AA 1-333)
Kurzübersicht für CIITA Antikörper (AA 1-333) (ABIN221164)
Target
Alle CIITA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-333
-
Spezifität
- The immunogen used for this study was a bacterially produced recombinant FLAG-CIITA corresponding to amino acids 1 through 333 of the human protein.
-
Aufreinigung
- Delipidated and defibrinated
-
Immunogen
-
Recombinant human CIITA.
Type of Immunogen: Recombinant protein
-
-
-
-
Applikationshinweise
- Approved: ELISA, WB (1:500)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Serum - liquid, 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid cycles of freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store vial at -20°C or below prior to opening. Dilute only prior to immediate use. Aliquot contents and freeze at -20°C or below. Avoid freeze-thaw cycles.
-
-
- CIITA (Class II, Major Histocompatibility Complex, Transactivator (CIITA))
-
Andere Bezeichnung
- CIITA
-
Hintergrund
-
Name/Gene ID: CIITA
Synonyms: CIITA, C2TA, MHC class II transactivator, MHC2TA, CIITAIV, NLRA -
Gen-ID
- 4261
-
UniProt
- P33076
-
Pathways
- Cancer Immune Checkpoints
Target
-